NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.



Don't have an account? Register

ADVERTISEMENT

ADVERTISEMENT

New group set to provide ‘solutions’ for clinical trials system

By Reporter - 11th Jul 2024

ISR spring meeting

The newly established  national clinical trials oversight group will propose “sustainable solutions”,  with a view to creating “more efficiencies” in the clinical trials system.

The group is tasked with developing recommendations to increase the number of trials taking place in Ireland. The first meeting of the group took place today (Thursday 11 July).

According to a statement from the Department of Health, Ireland is not attracting as many clinical trials as some other European countries. National initiatives have been implemented and additional steps are being taken to address this and improve the clinical trial landscape in Ireland.

“Solutions are required to address challenges that remain, including, the excessive administrative burdens, workforce, and operational resources, as well as slow start-up speeds.”

The Minister for Health Stephen Donnelly said the group has been established to “propose tangible, innovative solutions”.

“Improvements have the potential to make an enormous difference to patients. I would like to thank the chair, Prof Donal Brennan, and all the members of the group, for their commitment in progressing the important work of this group.”

It is envisioned that the oversight group will be operational for a period of one year.

Prof Brennan, said he was honoured to take up the position of Chair. “There is now irrefutable evidence that increased research activity correlates with improved clinical outcomes across multiple healthcare systems, particularly when patients participate in clinical trials.”

“I hope that this group can work together to make Ireland a destination of choice for clinical trials, whereby patients can access new medicines and technologies in a safe, efficient, ethical and transparent fashion.”

Leave a Reply

ADVERTISEMENT

Latest

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Latest Issue
medical independent 9th July
Medical Independent 9th July 2024

You need to be logged in to access this content. Please login or sign up using the links below.

ADVERTISEMENT

Trending Articles

ADVERTISEMENT